[Efficacy and safety analysis of BCL-2 inhibitor in relapsed/refractory multiple myeloma with t (11;14) in a single center]

Autor:	J Y, Bi, L, Wen, W B, Duan, Y, Liu, S S, Wang, X J, Huang, J, Lu
Rok vydání:	2022
Předmět:	Proto-Oncogene Proteins c-bcl-2 Antineoplastic Combined Chemotherapy Protocols Humans Antineoplastic Agents Neoplasm Recurrence Local Multiple Myeloma Dexamethasone
Zdroj:	Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 43(2)
ISSN:	0253-2727
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::73f4af7c8aebf7f7eeabcd8e98194542 https://pubmed.ncbi.nlm.nih.gov/35381676 Zobrazit plný text záznamu